2019
Missed Opportunities for HPV Vaccination Among Vaccine-Eligible Women with High Grade Cervical Lesions
Russ SM, Brackney M, Meek J, Niccolai LM. Missed Opportunities for HPV Vaccination Among Vaccine-Eligible Women with High Grade Cervical Lesions. Vaccine 2019, 37: 4262-4267. PMID: 31248688, DOI: 10.1016/j.vaccine.2019.06.061.Peer-Reviewed Original ResearchConceptsHigh-grade cervical lesionsVaccine-eligible womenHPV vaccinationHPV diagnosisProvider recommendationCervical lesionsLog-binomial analysisHuman papillomavirus vaccineCervical intraepithelial neoplasiaStatewide surveillance systemCochran-Armitage trend testSelf-reported barriersArmitage trend testEligible patientsChart reviewHPV vaccinePapillomavirus vaccineVaccination statusCIN 2Intraepithelial neoplasiaVaccine eligibilityPatient interviewsVaccine historyNew Haven CountyVaccination
2018
Trends in High-grade Cervical Lesions and Cervical Cancer Screening in 5 States, 2008–2015
Gargano JW, Park IU, Griffin MR, Niccolai LM, Powell M, Bennett NM, Jones ML, Whitney E, Pemmaraju M, Brackney M, Abdullah N, Scahill M, Dahl RM, Cleveland AA, Unger ER, Markowitz LE, Blankenship S, Allen S, Meek J, Higgins K, Hadler J, Sosa L, Saadeh K, Williamson A, Fink D, Silverberg M, Laing R, Schafer S, Oktapodas M, Felsen C. Trends in High-grade Cervical Lesions and Cervical Cancer Screening in 5 States, 2008–2015. Clinical Infectious Diseases 2018, 68: 1282-1291. PMID: 30137283, PMCID: PMC6783904, DOI: 10.1093/cid/ciy707.Peer-Reviewed Original ResearchConceptsCervical cancer screeningIncidence rate ratiosCancer screeningCervical cancer screening recommendationsPopulation-based laboratory surveillanceAge groupsHigh-grade cervical lesionsHuman papillomavirus vaccine uptakeCancer screening recommendationsCervical intraepithelial neoplasiaPercent of womenHPV vaccinationScreening recommendationsIntraepithelial neoplasiaVaccine uptakeCervical lesionsLaboratory surveillanceCIN2Population-level impactWomenRate ratioSignificant decreaseYearsScreeningAdenocarcinoma
2017
Declines in Human Papillomavirus (HPV)–Associated High-Grade Cervical Lesions After Introduction of HPV Vaccines in Connecticut, United States, 2008–2015
Niccolai LM, Meek JI, Brackney M, Hadler JL, Sosa LE, Weinberger DM. Declines in Human Papillomavirus (HPV)–Associated High-Grade Cervical Lesions After Introduction of HPV Vaccines in Connecticut, United States, 2008–2015. Clinical Infectious Diseases 2017, 65: 884-889. PMID: 28520854, DOI: 10.1093/cid/cix455.Peer-Reviewed Original ResearchConceptsCervical cancer screeningCervical lesionsRisk behaviorsHPV vaccinationVaccination coverageHuman papillomavirusCancer screeningBirth cohortHigh-grade cervical lesionsHPV vaccination coverageRates of CIN2Cervical intraepithelial neoplasiaHigh-grade lesionsSexual risk behaviorsSignificant declineHPV vaccineVaccine impactIntraepithelial neoplasiaCervical cancerRisk factorsSurveillance periodSimilar epidemiologyChlamydia trachomatisCohort patternsNegative binomial regression